| Literature DB >> 22190959 |
Pietro Gambadauro1, Johannes Gudmundsson, Rafael Torrejón.
Abstract
Uterine fibroids are common in women of reproductive age and various conservative treatments are available. In order to achieve a successful conservative treatment of fibroids, functional integrity of the uterus is as important as tumor removal or symptoms relief. In this context, intrauterine adhesions must be recognized as a possible complication of conservative management of uterine fibroids, but diagnostic pitfalls might justify an underestimation of their incidence. Hysteroscopic myomectomy can cause adhesions as a result of surgical trauma to the endometrium. The average reported incidence is around 10% at second-look hysteroscopy, but it is higher in certain conditions, such as the case of multiple, apposing fibroids. Transmural myomectomies also have the potential for adhesion, especially when combined with uterine ischemia. Uterine arteries embolization also carries a risk of intracavitary adhesions. Prevention strategies including bipolar resection, barrier gel or postoperative estradiol, might be useful, but stronger evidence is needed. In view of current knowledge, we would recommend a prevention strategy based on a combination of surgical trauma minimization and identification of high-risk cases. Early hysteroscopic diagnosis and lysis possibly represents the best means of secondary prevention and treatment of postoperative intrauterine adhesions.Entities:
Year: 2011 PMID: 22190959 PMCID: PMC3236427 DOI: 10.1155/2012/853269
Source DB: PubMed Journal: Obstet Gynecol Int ISSN: 1687-9597
Intrauterine synechiae following resectoscopic myomectomy. Second-look hysteroscopy.
| Author | Instrument | Second-look interval | Fibroids | Additional treatment | Adhesions/second-look hysteroscopies | Adhesion rate |
|---|---|---|---|---|---|---|
|
Taskin et al. 2000 [ | monopolar | 14–30 days | single | no/placebo | 8/22 | 36.36% |
| Danazol | 7/20 | 35% | ||||
| multiple | no/placebo | 6/13 | 46.15% | |||
| Danazol | 6/14 | 42.85% | ||||
|
| ||||||
|
Guida et al. 2004 [ | bipolar | 3 months | single* | no/placebo | 8/24 | 33.33% |
| a–c hyaluronic acid gel | 4/25 | 16% | ||||
|
| ||||||
|
Yang et al. 2008 [ | monopolar* | 1–3 months | single | No | 2/132 | 1.5% |
| 2, nonapposing | IUD, 1 month | 0/5 | 0% | |||
| ≥2 apposing | IUD, 1 month | 7/9 | 78% | |||
| ≥2 apposing | early lysis 1-2 weeks | 0/7 | 0% | |||
|
| ||||||
| Touboul et al. 2009 [ | bipolar | 2 months | single* | No | 4/53 | 7.5% |
|
| ||||||
|
Roy et al. 2010 [ | monopolar | 6 weeks | single | estradiol valerate (6 weeks) antibiotics (5 days) | 2/186 | 1.07% |
|
| ||||||
| Total | 54/510 | 10.58% | ||||
*Extrapolated, but not clearly stated on the original paper.